Mouhsin Shafi, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 24 | 2023 | 1432 | 3.630 |
Why?
|
Electroencephalography | 40 | 2023 | 6150 | 3.100 |
Why?
|
Motor Cortex | 8 | 2023 | 986 | 2.800 |
Why?
|
Seizures | 15 | 2023 | 2859 | 1.590 |
Why?
|
Evoked Potentials, Motor | 7 | 2023 | 454 | 1.250 |
Why?
|
Theta Rhythm | 4 | 2023 | 207 | 1.100 |
Why?
|
Epilepsy | 6 | 2023 | 3310 | 0.790 |
Why?
|
Delirium | 7 | 2023 | 1609 | 0.790 |
Why?
|
Nerve Net | 8 | 2022 | 2174 | 0.780 |
Why?
|
Brain Waves | 5 | 2017 | 401 | 0.730 |
Why?
|
Alzheimer Disease | 10 | 2023 | 8037 | 0.690 |
Why?
|
Evoked Potentials, Auditory | 1 | 2022 | 525 | 0.660 |
Why?
|
Brain | 18 | 2022 | 26385 | 0.660 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2016 | 57 | 0.640 |
Why?
|
Pyramidal Tracts | 1 | 2017 | 256 | 0.530 |
Why?
|
Neuronal Plasticity | 3 | 2020 | 1422 | 0.510 |
Why?
|
Magnetic Field Therapy | 1 | 2014 | 28 | 0.490 |
Why?
|
Brain Mapping | 5 | 2020 | 6669 | 0.450 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2018 | 1018 | 0.430 |
Why?
|
Computational Biology | 1 | 2022 | 3521 | 0.350 |
Why?
|
Models, Theoretical | 3 | 2017 | 3589 | 0.340 |
Why?
|
Cerebral Cortex | 3 | 2015 | 5708 | 0.290 |
Why?
|
Affect | 1 | 2014 | 1476 | 0.280 |
Why?
|
Reproducibility of Results | 10 | 2023 | 19905 | 0.280 |
Why?
|
Memory, Short-Term | 3 | 2015 | 975 | 0.250 |
Why?
|
Humans | 61 | 2023 | 744343 | 0.220 |
Why?
|
Long-Term Potentiation | 2 | 2021 | 293 | 0.210 |
Why?
|
Young Adult | 14 | 2022 | 56430 | 0.210 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5391 | 0.200 |
Why?
|
Glasgow Outcome Scale | 2 | 2018 | 109 | 0.200 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2015 | 403 | 0.190 |
Why?
|
Neural Pathways | 1 | 2012 | 2972 | 0.190 |
Why?
|
Rest | 2 | 2023 | 901 | 0.180 |
Why?
|
Monitoring, Physiologic | 3 | 2018 | 1738 | 0.160 |
Why?
|
Male | 29 | 2022 | 350118 | 0.160 |
Why?
|
Evoked Potentials | 2 | 2023 | 1056 | 0.150 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 436 | 0.150 |
Why?
|
Cognitive Reserve | 1 | 2017 | 76 | 0.150 |
Why?
|
Aged | 20 | 2023 | 163280 | 0.150 |
Why?
|
Bipolar Disorder | 1 | 2014 | 5027 | 0.150 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4644 | 0.140 |
Why?
|
Adult | 22 | 2022 | 214055 | 0.140 |
Why?
|
Piracetam | 1 | 2017 | 87 | 0.140 |
Why?
|
Middle Aged | 22 | 2022 | 213383 | 0.130 |
Why?
|
Nootropic Agents | 1 | 2017 | 160 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 11725 | 0.130 |
Why?
|
Female | 28 | 2022 | 380194 | 0.130 |
Why?
|
Foramen Ovale | 1 | 2014 | 14 | 0.120 |
Why?
|
Pyrazines | 1 | 2020 | 1230 | 0.120 |
Why?
|
Brain Ischemia | 2 | 2018 | 3265 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 1011 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2022 | 57776 | 0.110 |
Why?
|
Visual Pathways | 1 | 2017 | 565 | 0.110 |
Why?
|
Critical Care | 2 | 2017 | 2647 | 0.110 |
Why?
|
Electromyography | 1 | 2017 | 1379 | 0.110 |
Why?
|
Intelligence | 1 | 2017 | 920 | 0.100 |
Why?
|
Neurosciences | 1 | 2016 | 348 | 0.100 |
Why?
|
Amyloid beta-Peptides | 2 | 2023 | 3587 | 0.100 |
Why?
|
Neurons | 2 | 2007 | 9338 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2023 | 15295 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 6 | 2023 | 35421 | 0.090 |
Why?
|
Haplorhini | 2 | 2007 | 552 | 0.080 |
Why?
|
Memory Disorders | 1 | 2015 | 1184 | 0.080 |
Why?
|
Executive Function | 1 | 2017 | 1364 | 0.080 |
Why?
|
Brain Diseases | 1 | 2017 | 1563 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.070 |
Why?
|
Cognition | 3 | 2020 | 6770 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2021 | 77449 | 0.070 |
Why?
|
Anticonvulsants | 2 | 2018 | 1916 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 1534 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1622 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2016 | 3679 | 0.070 |
Why?
|
Extracellular Space | 1 | 2007 | 594 | 0.060 |
Why?
|
Electrophysiology | 1 | 2007 | 1308 | 0.060 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 69 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2015 | 3748 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2015 | 2147 | 0.050 |
Why?
|
Parietal Lobe | 1 | 2007 | 838 | 0.050 |
Why?
|
Brain Injuries | 1 | 2014 | 2025 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 40561 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39050 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2716 | 0.050 |
Why?
|
Spin Labels | 1 | 2023 | 332 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.050 |
Why?
|
Somatosensory Cortex | 1 | 2005 | 528 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.050 |
Why?
|
Time | 1 | 2022 | 542 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2023 | 572 | 0.050 |
Why?
|
Risk | 1 | 2012 | 9687 | 0.050 |
Why?
|
Selection Bias | 1 | 2022 | 371 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15076 | 0.040 |
Why?
|
Hippocampus | 2 | 2023 | 3675 | 0.040 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 398 | 0.040 |
Why?
|
Mental Recall | 2 | 2017 | 1205 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8324 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5255 | 0.040 |
Why?
|
Amyloid | 1 | 2023 | 795 | 0.040 |
Why?
|
Algorithms | 4 | 2016 | 13881 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14722 | 0.040 |
Why?
|
Time Factors | 3 | 2016 | 40075 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1360 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2023 | 6993 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 72290 | 0.040 |
Why?
|
Mental Disorders | 1 | 2016 | 6600 | 0.040 |
Why?
|
Critical Illness | 2 | 2022 | 2670 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2017 | 447 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6234 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 21746 | 0.030 |
Why?
|
Periodicity | 1 | 2017 | 363 | 0.030 |
Why?
|
Adolescent | 4 | 2021 | 85781 | 0.030 |
Why?
|
Aging | 2 | 2023 | 8664 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 981 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3341 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 379 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2731 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2014 | 635 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2017 | 12026 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 454 | 0.030 |
Why?
|
Verbal Learning | 1 | 2014 | 467 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2951 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.020 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 315 | 0.020 |
Why?
|
Memory | 1 | 2020 | 2174 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2886 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1590 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2737 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2014 | 824 | 0.020 |
Why?
|
Teaching | 1 | 2017 | 1174 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5317 | 0.020 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1197 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6365 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1901 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8663 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 2025 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6038 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
Models, Neurological | 1 | 2013 | 1774 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2011 | 2309 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5102 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
Anesthesia | 1 | 2013 | 1561 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2014 | 3528 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4189 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13989 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168757 | 0.010 |
Why?
|
Action Potentials | 1 | 2005 | 1806 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7279 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 12804 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|